content top

Clinical Experience of Ocriplasmin for Vitreomacular Traction and MH

Purpose: To evaluate the anatomical and functional results after ocriplasmin (JETREA, ThromboGenics NV, Iselin, NJ, USA) injection in patients with vitreomacular traction (VMT) with or without macular hole (MH). Methods: Fifteen prospective patients with VMT were treated with a single ocriplasmin injection and followed-up at baseline, 1 week, 1, 3 and 6 months. ETDRS best-corrected visual acuity (BCVA), intraocular pressure and...

Read More

Dome-shaped Macula in Non Myopic Patients; Description and Management

Advantages: Gaucher et al. described an unusual feature in myopic eyes responsible for visual loss called Dome-Shaped macula (D-Sh-M). This condition was defined as a convex elevation of macula within a staphyloma in highly myopic patients as diagnosed by OCT. Moreover, this entity was associated with RPE atrophic changes, foveal retinal detachment and visual impairment. Afterwards, Imamura et al. examined the posterior anatomic...

Read More
content top